|
![]() |
|||
|
||||
OverviewSignificant advances have been made in the diagnosis and treatment of osteoporosis in the last ten years that have greatly improved the health outcomes for many patients. However, despite these advances, osteoporosis still poses major clinical challenges to the clinician. Non-adherence to drug therapy is a widespread problem in patients with rheumatic diseases and osteoporosis in particular. Part of the Oxford Rheumatology Library and written by one of the co-authors of the Oxford Handbook of Rheumatology, this pocketbook summarizes the latest developments in the management of osteoporosis and serves as a practical resource for trainees in rheumatology, endocrinology and geriatric medicine, as well as general practitioners and paramedical staff involved in osteoporosis care. Full Product DetailsAuthor: Gavin Clunie , Richard KeenPublisher: Oxford University Press Imprint: Oxford University Press Dimensions: Width: 10.00cm , Height: 1.00cm , Length: 18.00cm Weight: 0.176kg ISBN: 9780199234172ISBN 10: 0199234175 Pages: 208 Publication Date: 20 December 2007 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Out of Print Availability: In Print ![]() Limited stock is available. It will be ordered for you and shipped pending supplier's limited stock. Table of ContentsOSTEOPOROSIS: THE FUNDAMENTAL ASPECTS OF THE CONDITION; 1. Pathophysiology of Osteoporosis; 2. Epidemiology including fragility fracture; 3. Diagnosis of osteoporosis; 4. Osteoporosis risk assessment in women; MANAGEMENT OF POSTMENOPAUSAL OSTEOPOROSIS: THERAPIES; 5. Fracture liaison services; 6. Calcium and vitamin-D therapy; 7. Bisphosphonates; 8. HRT and SERMs; 9. Strontium Ranelate; 10. rhPTH preparations; 11. New and future drug treatments; 12. Vertebroplasty and kyphoplasty; 13. Physical therapies; MANAGEMENT OF OSTEOPOROSIS: SPECIFIC PATIENT GROUPS; 14. Osteoporosis in men; 15. Glucortoid (steroid) induced osteoporosis; 16. Osteoporosis associated with breast cancer and women on aromatase inhibitor drugs; 17. Osteoporosis and bone fragility in chronic kidney disease; 18. Pre-menopausal osteoporosis; 19. Osteoporosis in children and adolescents; 20. Assessment and management of falls; 21. Appendix, useful links, internet resources and patient organisationsReviewsAuthor InformationGavin Clunie is a Consultant Rheumatologist with a sub-specialist interest in metabolic bone diseases. He trained in London and has worked in Ipswich since 2000. He is also a clinical advisor to the Arthritis Research Campaign (ARC). Richard Keen trained at St. Mary's Hospital, London and is currently a Consultant Rheumatologist at the Royal National Orthopaedic Hospital, Stanmore. He also holds an Honorary Senior Lecturer appointment at University College London. Tab Content 6Author Website:Countries AvailableAll regions |